NSW Increases Penalties and Enforcement for Illegal Vape Supply

Nov.19.2024
NSW Increases Penalties and Enforcement for Illegal Vape Supply
The New South Wales Government in Australia has introduced tougher penalties and enforcement measures for illegal vape supply, increasing fines to A$1.54 million and prison terms to seven years.

On November 19, the New South Wales (NSW) Government announced plans to raise the maximum fine for illegal vape supply from A$1,650 to approximately A$1.54 million, with prison sentences increasing from six months to seven years.

 

The NSW Government has introduced the legislation in Parliament, aiming to align state enforcement powers with those of federal agencies. Possession of a commercial quantity of vaping products or retailer possession of vapes will also be classified as illegal.

 

Similar to the Commonwealth vaping reforms, these measures target suppliers of vape products rather than individual users. Over the past year, more than 300,000 vape products have been seized by the government.

 

Between July 1 and September 30, 2024, a total of 362 inspections were conducted, resulting in the seizure of 42,000 products. In comparison, 153,000 products were confiscated from 290 inspections last year. The recent decrease in seizures during the last quarter may reflect market supply disruptions following the implementation of new Commonwealth vaping laws.

 

In October, the NSW Government announced plans to recruit 14 additional enforcement officers to enhance compliance efforts for vaping and tobacco products statewide. 

 

Additionally, they also launched the eCigarette Compliance Program, initially aimed at supporting pharmacists. A dedicated team of compliance officers will visit pharmacies across the state to provide on-site education and guidance.

 

"The prevalence of illegal vaping devices in our community, and in particular among our young people, is deeply concerning. We have a once-in-a-generation opportunity to the stem the tide of this public health challenge," said Ryan Park, the state Minister for Health, 

 

"I am very encouraged by the progress we are making in terms of removing these harmful devices from our streets. And I am pleased to announce that we are augmenting our efforts by introducing harsher penalties to target suppliers."

 

 

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03